MedTrace Logo

Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam

NCT00131820 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100742

Last updated 2008-03-13

No results posted yet for this study

Summary

This study is part of International Vaccine Institutes (IVI)'s typhoid Vi demonstration project that aims to accelerate the rational introduction of Vi vaccines in typhoid endemic countries. The primary objectives of the study are to evaluate the logistic feasibility of a mass typhoid fever immunization campaign program targeting school age children in Hue City, Vietnam and to assess the knowledge, attitudes, beliefs, and practices of parents and healthcare providers in Hue City regarding typhoid fever prevention and treatment.

Conditions

  • Typhoid
  • Paratyphoid Fever

Interventions

BIOLOGICAL

Typhoid Vi vaccine

BIOLOGICAL

Hepatitis A (control)

Sponsors & Collaborators

  • National Institute of Hygiene and Epidemiology, Vietnam

    collaborator OTHER

  • Hue Preventive Medicine Center, Vietnam

    collaborator UNKNOWN

  • Wellcome Trust

    collaborator OTHER

  • University of Western Ontario, Canada

    collaborator OTHER

  • GlaxoSmithKline

    collaborator INDUSTRY

  • International Vaccine Institute

    lead OTHER

Principal Investigators

  • Canh G Do, MD · National Institute of Hygiene and Epidemiology, Vietnam

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-12-31
Primary Completion
2007-01-31
Completion
2007-01-31

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00131820 on ClinicalTrials.gov